Argenx
ARGX
#440
Rank
ยฃ41.79 B
Marketcap
ยฃ664.57
Share price
-3.93%
Change (1 day)
4.08%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: ยฃ41.79 Billion

As of November 2026 Argenx has a market cap of ยฃ41.79 Billion. This makes Argenx the world's 440th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ41.79 B6.96%
2025ยฃ39.07 B30.92%
2024ยฃ29.84 B68.48%
2023ยฃ17.71 B2.25%
2022ยฃ17.32 B27.16%
2021ยฃ13.62 B32.44%
2020ยฃ10.28 B96.11%
2019ยฃ5.24 B89.91%
2018ยฃ2.76 B86.2%
2017ยฃ1.48 B
2014ยฃ93.47 M

End of Day market cap according to different sources

On Nov 4th, 2026 the market cap of Argenx was reported to be:

ยฃ42.93 Billion
by Nasdaq info icon info icon
ยฃ43.50 Billion
by CompaniesMarketCap info icon info icon